These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32728149)

  • 41. [Assessment of diabetic alterations of microcirculation by means of capillaroscopy and laser-Doppler anemometry].
    Meyer MF; Pfohl M; Schatz H
    Med Klin (Munich); 2001 Feb; 96(2):71-7. PubMed ID: 11253285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of oral paricalcitol therapy on arterial stiffness and osteopontin in hypertensive patients with chronic kidney disease and secondary hyperparathyroidism.
    Giakoumis M; Tsioufis C; Dimitriadis K; Sonikian M; Kasiakogias A; Andrikou E; Kalos T; Konstantinidis D; Filis K; Petras D; Tousoulis D
    Hellenic J Cardiol; 2019; 60(2):108-113. PubMed ID: 29305902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arterial stiffness evaluated by carotid-femoral pulse wave velocity increases the risk of chronic kidney disease in a Chinese population-based cohort.
    Kong X; Ma X; Tang L; Wang Z; Li W; Cui M; Xu D
    Nephrology (Carlton); 2017 Mar; 22(3):205-212. PubMed ID: 26890606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Compliance Index, a Marker of Peripheral Arterial Stiffness, may Predict Renal Function Decline in Patients with Chronic Kidney Disease.
    Kuo TH; Yang DC; Lin WH; Tseng CC; Chen JY; Ho CS; Cheng MF; Tsai WC; Wang MC
    Int J Med Sci; 2015; 12(7):530-7. PubMed ID: 26180508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Relationship between Carotid and Femoral Artery Intima-Media Thickness and Histopathologic Grade of Atherosclerosis in Patients with Chronic Kidney Disease.
    Nezami N; Ghabili K; Shokouhi-Gogani B; Mirchi M; Ghojazadeh M; Safa J; Zomorrodi A; Gharadaghi A; Mojadidi MK; Tarzamni MK; Khajir G; Ghorashi S; Revzin M
    Nephron; 2018; 139(2):159-169. PubMed ID: 29514148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD.
    Gracia M; Betriu À; Martínez-Alonso M; Arroyo D; Abajo M; Fernández E; Valdivielso JM;
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):287-96. PubMed ID: 26668022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between arterial stiffness and chronic kidney disease in patients with primary hypertension.
    Zuo J; Hu Y; Chang G; Chu SL; Tan I; Butlin M; Avolio A
    J Hum Hypertens; 2020 Sep; 34(8):577-585. PubMed ID: 31664172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of arterial stiffness in nondiabetic chronic kidney disease patients.
    Mastanvalli B; Kumar KP; Madhav D; Venkata Pakki Reddy PL; Vali SM
    Saudi J Kidney Dis Transpl; 2017; 28(1):61-67. PubMed ID: 28098104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impaired vascular function contributes to exercise intolerance in chronic kidney disease.
    Van Craenenbroeck AH; Van Craenenbroeck EM; Van Ackeren K; Hoymans VY; Verpooten GA; Vrints CJ; Couttenye MM
    Nephrol Dial Transplant; 2016 Dec; 31(12):2064-2072. PubMed ID: 27540045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between serum 25-hydroxyvitamin D levels and carotid atherosclerosis in chronic kidney disease patients.
    Ng YM; Lim SK; Kang PS; Kadir KA; Tai MS
    BMC Nephrol; 2016 Oct; 17(1):151. PubMed ID: 27756244
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial.
    Lioufas NM; Pedagogos E; Hawley CM; Pascoe EM; Elder GJ; Badve SV; Valks A; Toussaint ND;
    Am J Nephrol; 2020; 51(3):201-215. PubMed ID: 32023606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Undercarboxylated osteocalcin as a biomarker of subclinical atherosclerosis in non-dialysis patients with chronic kidney disease.
    Zhang M; Ni Z; Zhou W; Qian J
    J Biomed Sci; 2015 Sep; 22(1):75. PubMed ID: 26381729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease.
    Dursun I; Poyrazoglu HM; Gunduz Z; Ulger H; Yykylmaz A; Dusunsel R; Patyroglu T; Gurgoze M
    Nephrol Dial Transplant; 2009 Aug; 24(8):2511-8. PubMed ID: 19244228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease.
    Yilmaz G; Ustundag S; Temizoz O; Sut N; Demir M; Ermis V; Sevinc C; Ustundag A
    Clin Lab; 2015; 61(8):1061-70. PubMed ID: 26427152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of arterial stiffness in patients with CKD stage 5 when initiating chronic hemodialysis for vascular access and for preventing cardiovascular events.
    Mateş A; Golea O; Tudoran M; Tudoran C; Pescariu S; Velciov S
    Rom J Intern Med; 2012; 50(3):225-31. PubMed ID: 23330290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uricemia and homocysteinemia: nontraditional risk factors in the early stages of chronic kidney disease--preliminary data.
    Lai S; Mariotti A; Coppola B; Lai C; Aceto P; Dimko M; Galani A; Innico G; Frassetti N; Mangiulli M; Cianci R
    Eur Rev Med Pharmacol Sci; 2014; 18(7):1010-7. PubMed ID: 24763881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pediatric CKD and cardiovascular disease.
    Safder O; Al sharif S; Kari JA
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(3):177-84. PubMed ID: 24720458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease.
    Karras A; Haymann JP; Bozec E; Metzger M; Jacquot C; Maruani G; Houillier P; Froissart M; Stengel B; Guardiola P; Laurent S; Boutouyrie P; Briet M;
    Hypertension; 2012 Dec; 60(6):1451-7. PubMed ID: 23090769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paricalcitol, Microvascular and Endothelial Function in Non-Diabetic Chronic Kidney Disease: A Randomized Trial.
    Lundwall K; Jörneskog G; Jacobson SH; Spaak J
    Am J Nephrol; 2015; 42(4):265-73. PubMed ID: 26496210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced systemic microvascular density and reactivity in individuals with early onset coronary artery disease.
    Tibirica E; Souza EG; De Lorenzo A; Oliveira GM
    Microvasc Res; 2015 Jan; 97():105-8. PubMed ID: 25446366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.